c-Abl: activation and nuclear targets

[1]  Jijie Gu,et al.  p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage , 1999, Nature.

[2]  Reuven Agami,et al.  Interaction of c-Abl and p73α and their collaboration to induce apoptosis , 1999, Nature.

[3]  Antonio Costanzo,et al.  The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage , 1999, Nature.

[4]  C. Pabo,et al.  Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins , 1999, Nature.

[5]  Jean Y. J. Wang,et al.  Nuclear c-Abl Is a COOH-Terminal Repeated Domain (CTD)-Tyrosine Kinase-specific for the Mammalian RNA Polymerase II: Possible Role in Transcription Elongation , 1999 .

[6]  R. A. Etten.  Cycling, stressed-out and nervous: cellular functions of c-Abl , 1999 .

[7]  D. Baltimore,et al.  Radiation-induced Assembly of Rad51 and Rad52 Recombination Complex Requires ATM and c-Abl* , 1999, The Journal of Biological Chemistry.

[8]  M. Oren,et al.  c-Abl Neutralizes the Inhibitory Effect of Mdm2 on p53* , 1999, The Journal of Biological Chemistry.

[9]  J. Wang,et al.  Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells , 1999, British Journal of Cancer.

[10]  T. Tsuruo,et al.  Activation of c-Abl tyrosine kinase requires caspase activation and is not involved in JNK/SAPK activation during apoptosis of human monocytic leukemia U937 cells , 1999, Oncogene.

[11]  R. Agami,et al.  Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis. , 1999, Nature.

[12]  J. Wang,et al.  Nuclear c-Abl is a COOH-terminal repeated domain (CTD)-tyrosine (CTD)-tyrosine kinase-specific for the mammalian RNA polymerase II: possible role in transcription elongation. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[13]  D. Baltimore,et al.  Essential Roles for the Abl and Arg Tyrosine Kinases in Neurulation , 1998, Neuron.

[14]  Xinbin Chen,et al.  The potential tumor suppressor p73 differentially regulates cellular p53 target genes. , 1998, Cancer research.

[15]  S. Elledge,et al.  The DNA Replication and Damage Checkpoint Pathways Induce Transcription by Inhibition of the Crt1 Repressor , 1998, Cell.

[16]  L. Bracco,et al.  The requirement for the p53 proline‐rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression , 1998, The EMBO journal.

[17]  C. Bailly,et al.  The DNA binding domain of the human c-Abl tyrosine kinase preferentially binds to DNA sequences containing an AAC motif and to distorted DNA structures. , 1998, Biochemistry.

[18]  R. Agami,et al.  The kinase activity of c-Abl but not v-Abl is potentiated by direct interaction with RFXI, a protein that binds the enhancers of several viruses and cell-cycle regulated genes , 1998, Oncogene.

[19]  G. Superti-Furga,et al.  An intramolecular SH3-domain interaction regulates c-Abl activity , 1998, Nature Genetics.

[20]  P. Sung,et al.  Regulation of Rad51 Function by c-Abl in Response to DNA Damage* , 1998, The Journal of Biological Chemistry.

[21]  Zhi-Min Yuan,et al.  Pro-apoptotic effect of the c-Abl tyrosine kinase in the cellular response to 1-β-D-arabinofuranosylcytosine , 1997, Oncogene.

[22]  W. Kaelin,et al.  p73 is a human p53-related protein that can induce apoptosis , 1997, Nature.

[23]  R. Agami,et al.  The transcriptional activation and repression domains of RFX1, a context-dependent regulator, can mutually neutralize their activities. , 1997, Nucleic acids research.

[24]  A. Yang,et al.  Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers , 1997, Cell.

[25]  S. Aebi,et al.  Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin. , 1997, Cancer research.

[26]  D. Baltimore,et al.  Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation , 1997, Nature.

[27]  Y. Shiloh,et al.  Interaction between ATM protein and c-Abl in response to DNA damage , 1997, Nature.

[28]  S. Inoue,et al.  Functional interaction between DNA-PK and c-Abl in response to DNA damage , 1997, Nature.

[29]  R. Weichselbaum,et al.  Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  John Kuriyan,et al.  Crystal structure of the Src family tyrosine kinase Hck , 1997, Nature.

[31]  Michael J. Eck,et al.  Three-dimensional structure of the tyrosine kinase c-Src , 1997, Nature.

[32]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[33]  M. Kastan,et al.  p53 and ATM: cell cycle, cell death, and cancer. , 1997, Advances in cancer research.

[34]  R. A. Etten,et al.  The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity , 1997 .

[35]  M. Karin,et al.  Three distinct signalling responses by murine fibroblasts to genotoxic stress , 1996, Nature.

[36]  S. Goff,et al.  Increased sensitivity to apoptotic stimuli in c-abl-deficient progenitor B-cell lines. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[37]  C. Sawyers,et al.  Genotoxic Drugs Induce Interaction of the c-Abl Tyrosine Kinase and the Tumor Suppressor Protein p53* , 1996, The Journal of Biological Chemistry.

[38]  Jean Y. J. Wang,et al.  Binding of A/T-rich DNA by Three High Mobility Group-like Domains in c-Abl Tyrosine Kinase* , 1996, The Journal of Biological Chemistry.

[39]  R. Weichselbaum,et al.  Role for c-Abl tyrosine kinase in growth arrest response to DNA damage , 1996, Nature.

[40]  R. Weichselbaum,et al.  The stress response to ionizing radiation involoves c-Abl-dependent phosphorylation of SHPTP1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Jean Y. J. Wang,et al.  Differential Regulation of Retinoblastoma Protein Function by Specific Cdk Phosphorylation Sites (*) , 1996, The Journal of Biological Chemistry.

[42]  R. V. van Etten,et al.  The cytostatic function of c‐Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products. , 1996, The EMBO journal.

[43]  R. Agami,et al.  p140/c-Abl that binds DNA is preferentially phosphorylated at tyrosine residues. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[44]  S. Goff,et al.  Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity. , 1995, Genes & development.

[45]  A. Pendergast,et al.  Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity. , 1995, Genes & development.

[46]  P. J. Welch,et al.  Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms , 1995, Molecular and cellular biology.

[47]  R. Weichselbaum,et al.  Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents , 1995, Nature.

[48]  T. Hambuch,et al.  p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase. , 1995, Oncogene.

[49]  S. Chung,et al.  Deregulation of c-abl mediated cell growth after retroviral transfer and expression of antisense sequences. , 1995, Oncogene.

[50]  S. Lippard,et al.  A single HMG domain in high-mobility group 1 protein binds to DNAs as small as 20 base pairs containing the major cisplatin adduct. , 1995, Biochemistry.

[51]  J. Wang,et al.  Src homology 2 domain as a specificity determinant in the c-Abl-mediated tyrosine phosphorylation of the RNA polymerase II carboxyl-terminal repeated domain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[52]  A. Bardwell,et al.  Nucleotide excision repair in the yeast Saccharomyces cerevisiae: its relationship to specialized mitotic recombination and RNA polymerase II basal transcription. , 1995, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[53]  D. Baltimore,et al.  Modular binding domains in signal transduction proteins , 1995, Cell.

[54]  P. J. Welch,et al.  Disruption of retinoblastoma protein function by coexpression of its C pocket fragment. , 1995, Genes & development.

[55]  D. Baltimore,et al.  SH2 and SH3 domains as molecular adhesives: the interactions of Crk and Abl. , 1994, Trends in biochemical sciences.

[56]  D. Baltimore,et al.  Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase , 1994, Molecular and cellular biology.

[57]  C. Sawyers,et al.  The nuclear tyrosine kinase c-abl negatively regulates cell growth , 1994, Cell.

[58]  T Pawson,et al.  Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav , 1994, Molecular and cellular biology.

[59]  C. Ucla,et al.  RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins , 1994, Molecular and cellular biology.

[60]  P. Janmey,et al.  The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity [published erratum appears in J Cell Biol 1994 Mar;124(5):865] , 1994, The Journal of cell biology.

[61]  T. Pawson,et al.  SH2 and SH3 domains in signal transduction. , 1994, Advances in cancer research.

[62]  J. Wang,et al.  Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[63]  P. J. Welch,et al.  A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle , 1993, Cell.

[64]  S. Elledge,et al.  DNA damage and cell cycle regulation of ribonucleotide reductase , 1993, BioEssays : news and reviews in molecular, cellular and developmental biology.

[65]  J. Wang,et al.  An actin‐binding function contributes to transformation by the Bcr‐Abl oncoprotein of Philadelphia chromosome‐positive human leukemias. , 1993, The EMBO journal.

[66]  T. Pawson,et al.  SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.

[67]  P Cicchetti,et al.  Identification of a ten-amino acid proline-rich SH3 binding site. , 1993, Science.

[68]  D. Baltimore,et al.  Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. , 1992, Science.

[69]  Y. Shaul,et al.  c-abl has a sequence-specific enhancer binding activity , 1992, Cell.

[70]  Jean Y. J. Wang,et al.  Cell Cycle—Regulated Binding of c-Abl Tyrosine Kinase to DNA , 1992, Science.

[71]  J. Frost,et al.  Differential regulation of jun family gene expression by the tumor promoter okadaic acid. , 1991, The New biologist.

[72]  F. McCormick,et al.  Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[73]  R. Bronson,et al.  Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene , 1991, Cell.

[74]  S. Goff,et al.  Mice homozygous for the abl m1 mutation show poor viability and depletion of selected B and T cell populations , 1991, Cell.

[75]  Y. Shaul,et al.  Functional organization of the hepatitis B virus enhancer , 1990, Molecular and cellular biology.

[76]  D. Baltimore,et al.  The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization , 1989, Cell.

[77]  O. Witte,et al.  Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products , 1985, Molecular and cellular biology.